Ich stimme zu, dass diese Seite Cookies verwende. Weitere Informationen finden Sie unter unseren Datenschutzerklärungen .
X
Folwaczny, Alexander
7  Ergebnisse:
Personensuche X
?
1

Effect of PCSK9 inhibition with evolocumab on lipoprotein s..:

Waldmann, Elisa ; Wu, Liya ; Busygina, Kristina...
PLOS ONE.  17 (2022)  3 - p. e0265838 , 2022
Link: https://doi.org/10.1371/..
 
?
2

Postprandial Lipid Metabolism in Normolipidemic Subjects an..:

Folwaczny, Alexander ; Waldmann, Elisa ; Altenhofer, Julia..
Nutrients.  13 (2021)  5 - p. 1737 , 2021
Link: https://doi.org/10.3390/..
 
?
3

Effect of PCSK9 inhibition with evolocumab on lipoprotein s..:

Waldmann, Elisa ; Wu, Liya ; Busygina, Kristina...
1932-6203.  , 2022
Link: https://resolver.sub.uni..
 
?
4

Effect of PCSK9 inhibition with evolocumab on lipoprotein s..:

Elisa Waldmann ; Liya Wu ; Kristina Busygina...
https://doi.org/10.1371/journal.pone.0265838.  , 2022
Link: https://doi.org/10.1371/..
 
?
5

Effect of PCSK9 inhibition with evolocumab on lipoprotein s..:

Elisa Waldmann ; Liya Wu ; Kristina Busygina...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8942248/?tool=EBI.  , 2022
Link: https://doaj.org/article..
 
?
6

Postprandial Lipid Metabolism in Normolipidemic Subjects an..:

Alexander Folwaczny ; Elisa Waldmann ; Julia Altenhofer..
Nutrition and Metabolism.  , 2021
Link: https://doi.org/10.3390/..
 
?
7

Postprandial Lipid Metabolism in Normolipidemic Subjects an..:

Alexander Folwaczny ; Elisa Waldmann ; Julia Altenhofer..
https://www.mdpi.com/2072-6643/13/5/1737.  , 2021
Link: https://doi.org/10.3390/..
 
1-7